HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Patrick Marcellin Selected Research

Antiviral Agents (Antivirals)

7/2015Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis.
1/2015Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study.
1/2015IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.
2/2014Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.
2/2014Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir.
2/2014HCV direct-acting antiviral agents: the best interferon-free combinations.
2/2013Interferon free therapy with direct acting antivirals for HCV.
2/2012Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow.
1/2011New direct-acting antivirals' combination for the treatment of chronic hepatitis C.
1/2010Effect of newer oral antiviral agents on future therapy of chronic hepatitis B.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Patrick Marcellin Research Topics

Disease

67Chronic Hepatitis B
01/2016 - 01/2002
67Infection
11/2015 - 08/2002
55Chronic Hepatitis C
07/2015 - 01/2002
54Fibrosis (Cirrhosis)
11/2015 - 01/2002
48Hepatitis B
01/2016 - 01/2002
26Hepatitis C
04/2015 - 01/2002
11Liver Diseases (Liver Disease)
11/2015 - 01/2002
10Liver Cirrhosis (Hepatic Cirrhosis)
11/2013 - 02/2005
7Hepatocellular Carcinoma (Hepatoma)
10/2015 - 08/2006
5Hepatitis
04/2015 - 04/2003
5Insulin Resistance
10/2012 - 08/2007
4Inflammation
01/2012 - 01/2002
3Viremia
02/2014 - 07/2004
3Anemia
06/2011 - 01/2010
3Chronic Hepatitis (Chronic Active Hepatitis)
01/2010 - 09/2006
2Fatigue
08/2015 - 09/2004
2Neutropenia
02/2013 - 01/2012
2Body Weight (Weight, Body)
08/2011 - 06/2004
2HIV Infections (HIV Infection)
02/2008 - 12/2002
2Liver Failure
06/2005 - 07/2004
2Necrosis
06/2002 - 01/2002
1Chronic Disease (Chronic Diseases)
08/2015
1Peripheral Nervous System Diseases (PNS Diseases)
01/2015
1Vomiting
09/2012
1Drug Toxicity (Drug Safety)
08/2012
1Eye Infections
01/2012
1Lymphopenia (Lymphocytopenia)
01/2012
1Fatty Liver
11/2010
1Substance-Related Disorders (Drug Abuse)
09/2010
1Hemorrhage
05/2010

Drug/Important Bio-Agent (IBA)

67Ribavirin (Virazole)FDA LinkGeneric
08/2015 - 01/2002
58InterferonsIBA
07/2015 - 01/2002
47AntigensIBA
01/2016 - 01/2002
44Hepatitis B e AntigensIBA
09/2015 - 01/2002
24Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2016 - 06/2005
22DNA (Deoxyribonucleic Acid)IBA
10/2015 - 02/2003
18RNA (Ribonucleic Acid)IBA
06/2015 - 10/2002
15peginterferon alfa-2a (Pegasys)FDA Link
01/2015 - 02/2004
15adefovir dipivoxil (Hepsera)FDA Link
08/2013 - 02/2003
14Alanine Transaminase (SGPT)IBA
10/2015 - 10/2002
14Lamivudine (3TC)FDA Link
01/2012 - 01/2002
13tenofovir disoproxil (Viread)FDA Link
01/2016 - 12/2008
12Antiviral Agents (Antivirals)IBA
07/2015 - 10/2006
12Protease Inhibitors (Protease Inhibitor)IBA
05/2015 - 12/2010
12Interferon-alpha (Interferon Alfa)FDA Link
11/2007 - 01/2002
8N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2015 - 03/2011
8telaprevirIBA
01/2015 - 02/2011
8adefovirIBA
04/2014 - 12/2005
8tenofovirFDA Link
04/2014 - 03/2007
6Carbon MonoxideIBA
04/2015 - 02/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012 - 01/2002
4telbivudineFDA Link
01/2015 - 03/2007
4entecavirFDA Link
08/2013 - 03/2007
4CytokinesIBA
01/2012 - 01/2002
3F 4 (F-4)IBA
11/2015 - 02/2006
3emtricitabine (Emtriva)FDA Link
04/2014 - 03/2007
3ErythropoietinFDA Link
09/2013 - 08/2007
3Messenger RNA (mRNA)IBA
10/2010 - 02/2005
32'-fluoro-5-methylarabinosyluracil (Clevudine)IBA
12/2008 - 07/2004
3Transforming Growth Factor beta (TGF-beta)IBA
03/2007 - 01/2002
2Interferon Alfa-2a (Interferon Alfa 2a)FDA Link
08/2014 - 02/2004
2MicroRNAs (MicroRNA)IBA
06/2014 - 11/2012
2Circular DNAIBA
02/2014 - 06/2004
2InterleukinsIBA
02/2014 - 03/2012
2N- (17- (2- (4- isopropylthiazole- 2- yl)- 7- methoxy- 8- methylquinolin- 4- yloxy)- 13- methyl- 2,14- dioxo- 3,13- diazatricyclo(13.3.0.04,6)octadec- 7- ene- 4- carbonyl)(cyclopropyl)sulfonamideIBA
12/2013 - 01/2011
2Biological Markers (Surrogate Marker)IBA
01/2012 - 11/2002
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
08/2011 - 06/2006
2Insulin (Novolin)FDA Link
12/2010 - 08/2007
2lipoarabinomannan (LAM)IBA
05/2010 - 03/2009
2Proteins (Proteins, Gene)IBA
04/2009 - 03/2007
2Interleukin-8 (Interleukin 8)IBA
09/2008 - 03/2007
2AntibodiesIBA
11/2007 - 10/2007
2Lipoproteins (Lipoprotein)IBA
10/2007 - 08/2007
2peginterferon alfa-2b (Pegintron)FDA Link
04/2007 - 06/2004
1Vitamin DFDA LinkGeneric
11/2015
1Calcifediol (Calcidiol)FDA Link
11/2015
1hydroxide ionIBA
11/2015
1Ritonavir (Norvir)FDA Link
06/2015
1Hepatitis B Core AntigensIBA
04/2015
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2015
1Interferon-gamma (Interferon, gamma)IBA
02/2013
1LDL CholesterolIBA
10/2012
1MK-7009IBA
09/2012
1NK Cell Lectin-Like Receptor Subfamily CIBA
02/2012
1KIR ReceptorsIBA
02/2012
1Metalloproteases (Metalloproteinases)IBA
01/2012
1R1626IBA
01/2012
1Viral RNAIBA
06/2011
1Hepatitis B virus P proteinIBA
01/2011
1Neutralizing AntibodiesIBA
12/2010
1Viral DNAIBA
11/2010
1A-factor (Streptomyces)IBA
11/2010
1Street Drugs (Illicit Drugs)IBA
09/2010

Therapy/Procedure

10Liver Transplantation
02/2015 - 08/2002
5Transplantation (Transplant Recipients)
09/2014 - 08/2002
5Transplants (Transplant)
06/2008 - 08/2002
4Aftercare (After-Treatment)
08/2015 - 09/2008
4Retreatment
06/2012 - 04/2007
1Subcutaneous Injections
08/2014
1Drug Therapy (Chemotherapy)
08/2013